Main Content

Press Release


Interim report for the six-month period May 1 - October 31, 2005

• Order bookings rose 32 percent to SEK 1,997 M (1,515). The order backlog was on an all time high level of SEK 3,823 M.

• Net sales increased 32 percent to SEK 1,940 M (1,466).

• Operating profit amounted to SEK 153 M (179) and operating margins to 8 percent (12). On a rolling 12-month basis, operating margin was 9 percent.

• Profit after taxes amounted to SEK 98 M (124). Earnings per share after dilution amounted to SEK 1.03 (1.32).

• Cash flow after investments was negative SEK 51 M (neg. 10).

• In November, Elekta acquired Medical Intelligence Medizintechnik GmbH for a consideration of EUR 20 M, as part of a focused strategy to strengthen Elekta’s leadership in image guided and stereotactic radiation therapy.

For the full report, please see enclosed pdf file.

For further information, please contact:

Peter Ejemyr, Group VP Corporate Communications
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com


About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 1700 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For additional information about Elekta, please visit www.elekta.com.


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download:


PDF